Cargando…
3253 Identification of Immune Cell Profiles and Molecular Pathways in Inflammatory Bowel Disease Driving Non-Response to Biologic Therapy
OBJECTIVES/SPECIFIC AIMS: Inflammatory Bowel Disease (IBD) is a chronic, life-long condition characterized by inflammation of the intestine that greatly affects an individual’s quality of life. While biologic therapy directed against TNFα (anti-TNFα, Infliximab) and α4β7 integrin (anti-α4β7; Vedoliz...
Autores principales: | Penrose, Harrison Michael, Nakhoul, Hani, Ungerleider, Nathan, Flemington, Erik, Savkovic, Suzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798540/ http://dx.doi.org/10.1017/cts.2019.35 |
Ejemplares similares
-
2523 Noninvasive biomarkers for inflammatory bowel disease: Drawbacks and potential
por: Patel, Vihang, et al.
Publicado: (2018) -
Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
por: Penrose, Harrison M., et al.
Publicado: (2021) -
Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets
por: Penrose, Harrison M., et al.
Publicado: (2018) -
2045 The role of TGFβ in driving early cystic fibrosis lung disease
por: Kramer, Elizabeth L., et al.
Publicado: (2018) -
2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)